Vollenweider, F. X. & Preller, K. H. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nat. Rev. Neurosci. 21, 611–624 (2020).
Article CAS PubMed Google Scholar
Huang, J., Pham, M., Panenka, W. J., Honer, W. G. & Barr, A. M. Chronic treatment with psilocybin decreases changes in body weight in a rodent model of obesity. Front. Psychiatry 13, 891512 (2022).
Article PubMed PubMed Central Google Scholar
Fadahunsi, N. et al. Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice. Transl. Psychiatry 12, 330 (2022).
Article CAS PubMed PubMed Central Google Scholar
Volkow, N. D., Wang, G.-J., Tomasi, D. & Baler, R. D. Obesity and addiction: neurobiological overlaps. Obes. Rev. 14, 2–18 (2013).
Article CAS PubMed Google Scholar
Bogenschutz, M. P. et al. Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry 79, 953–962 (2022).
Article PubMed PubMed Central Google Scholar
Nutt, D. & Carhart-Harris, R. The current status of psychedelics in psychiatry. JAMA Psychiatry 78, 121–122 (2021).
Haahr, M. E. et al. Central 5-HT neurotransmission modulates weight loss following gastric bypass surgery in obese individuals. J. Neurosci. 35, 5884–5889 (2015).
Article CAS PubMed PubMed Central Google Scholar
Anderberg, R. H. et al. Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight. Diabetes 66, 1062–1073 (2017).
Article CAS PubMed Google Scholar
Simonsson, O., Sexton, J. D. & Hendricks, P. S. Associations between lifetime classic psychedelic use and markers of physical health. J. Psychopharmacol. 35, 447–452 (2021).
Article PubMed PubMed Central Google Scholar
Anderson, B. T., Danforth, A. L. & Grob, C. S. Psychedelic medicine: safety and ethical concerns. Lancet Psychiatry 7, 829–830 (2020).
留言 (0)